YH ENT (02306) bought back 198,000 shares for HKD 504,800 on October 22nd.
Lehoo Entertainment (02306) announced on October 22, 2025, that the company invested 504,800 Hong Kong dollars...
YH ENT (02306) announces that on October 22, 2025, the company will spend 500,000.48 Hong Kong dollars to repurchase 198,000 shares, with a repurchase price of 2.45-2.56 Hong Kong dollars per share.
Related Articles
Tonghua Dongbao Pharmaceutical (600867.SH): Recombinant Human Insulin Injection receives foreign drug registration certificate.
Beijing Foyou Pharma (601089.SH) has obtained the approval notice for the listing application of the raw material kelevoron.
Subsidiary of Shanghai Pharmaceuticals Holding (601607.SH) becomes the holder of the market authorization for Ammonium Sulphate Beicterb Tablets.
Tonghua Dongbao Pharmaceutical (600867.SH): Recombinant Human Insulin Injection receives foreign drug registration certificate.
Beijing Foyou Pharma (601089.SH) has obtained the approval notice for the listing application of the raw material kelevoron.
Subsidiary of Shanghai Pharmaceuticals Holding (601607.SH) becomes the holder of the market authorization for Ammonium Sulphate Beicterb Tablets.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
